Does Seasonal Influenza Vaccination Increase the Risk of Illness with the 2009 A/H1N1 Pandemic Virus?
article has not abstract
Vyšlo v časopise:
Does Seasonal Influenza Vaccination Increase the Risk of Illness with the 2009 A/H1N1 Pandemic Virus?. PLoS Med 7(4): e32767. doi:10.1371/journal.pmed.1000259
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000259
Souhrn
article has not abstract
Zdroje
1. HancockK
VeguillaV
LuX
ZhongW
ButlerEN
2009 Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361 1945 1952
2. ChowellG
BertozziSM
ColcheroMA
Lopez-GatellH
Alpuche-ArandaC
2009 Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361 674 679
3. MillerMA
ViboudC
BalinskaM
SimonsenL
2009 The signature features of influenza pandemics–implications for policy. N Engl J Med 360 2595 2598
4. SkowronskiD
De SerresG
CrowcroftN
al.E
2010 Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada. PLoS Med 7 e1000258 doi:10.1371/journal.pmed.1000258
5. SkowronskiDM
De SerresG
DickinsonJ
PetricM
MakA
2009 Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006–2007. J Infect Dis 199 168 179
6. GoodwinK
ViboudC
SimonsenL
2006 Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24 1159 696
7. FergusonNM
GalvaniAP
BushRM
2003 Ecological and immunological determinants of influenza evolution. Nature 422 428 433
8. EpsteinSL
2006 Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: An experiment of nature. J Infect Dis 193 49 53
9. SimonsenL
TaylorRJ
ViboudC
MillerMA
JacksonLA
2007 Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7 658 666
10. Garcia-GarciaL
Valdespino-GomezJL
Lazcano-PonceE
Jimenez-CoronaA
Higuera-IglesiasA
2009 Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: Case-control study in Mexico City. BMJ 339 b3928
11. Echevarria-ZunoS
Mejia-ArangureJM
Mar-ObesoAJ
Grajales-MunizC
Robles-PerezE
2009 Infection and death from influenza A H1N1 virus in Mexico: A retrospective analysis. Lancet 374 2072 2079
12. KellyH
GrantK
2009 Interim analysis of pandemic influenza (H1N1) 2009 in Australia: Surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 14
13. 2009 Effectiveness of 2008–09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May–June 2009. MMWR Morb Mortal Wkly Rep 58 1241 1245
14. IulianoAD
ReedC
GuhA
DesaiM
DeeDL
2009 Notes from the field: Outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April–May 2009. Clin Infect Dis 49 1811 1820
15. LesslerJ
ReichNG
CummingsDA
NairHP
JordanHT
2009 Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med 361 2628 2636
16. Crum-CianfloneNF
BlairPJ
FaixD
ArnoldJ
EcholsS
ShermanSS
Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. CID 2009; 49 1801 10
17. Public Health Agency of Canada October 2009 Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2009–2010. Available: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/09vol35/acs-dcc-6/index-eng.php. Accessed 25 February 2010
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 4
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility Analysis
- China's Engagement with Global Health Diplomacy: Was SARS a Watershed?
- Laboratory Capacity Building in Asia for Infectious Disease Research: Experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN)